Loading clinical trials...
Loading clinical trials...
Contrast Enhanced Voiding Urosonography (ceVUS) With the Intravesical Administration of the Ultrasound Contrast Agent OPTISON TM (Trademark) for Vesicoureteral Reflux Detection and Urethral Imaging in Children.
Conditions
Interventions
OPTISON
Locations
1
United States
Department of Radiology, the Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Start Date
July 1, 2014
Primary Completion Date
March 1, 2016
Completion Date
March 1, 2017
Last Updated
November 27, 2018
Lead Sponsor
Kassa Darge
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions